Caplight Directory>Companies>Kashiv BioSciences-preview>Kashivbiosciences


Kashiv BioSciences

Kashiv BioSciences

Private
Piscataway, New JerseyHealthcare & Life Scienceshttp://www.kashivbiosciences.com

Last Round

Debt

Dec 22, 2025

Total Funding Raised

$222M

Company Overview

Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biologics, biosimilars, and specialty pharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biosimilarsbiosimilar development505(b)(2) pathwaybiopharmaceutical manufacturingcomplex generic peptidesdrug delivery platformspharmaceutical licensingpharma partnershipsintegrated biopharmageneric biologicsB2B pharmaoncology biosimilarsdrug reformulationimmunology biosimilarsend-to-end drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kashiv BioSciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kashiv BioSciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtDec 22, 2025
DebtApr 7, 2025
DivestitureApr 5, 2021
View all Funding Rounds

Kashiv BioSciences Investors

Notable investors and investment history

InvestorRounds
GoldenTree Asset ManagementDebt
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Opened new manufacturing and R&D facilities to support Asian market growth.

  • Feb 10, 2026

    Partnered with Intas Pharmaceuticals for exclusive licensing and supply.

View all signals

Kashiv BioSciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kashiv BioSciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kashiv BioSciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPiscataway, New Jersey
Year Founded2010
Last FundingDec 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.